Status:
UNKNOWN
Echocardiography in Critically-ill Patients With COVID-19 Pneumonia
Lead Sponsor:
Hospital Ambroise Paré Paris
Conditions:
COVID
Sars-CoV2
Eligibility:
All Genders
Brief Summary
Critical care echocardiography (CCE) has been widely used since the 10 last years. Covid outbreak leads that many patients with acute respiratory failure were admitted in the ICU. Many of these patien...
Detailed Description
Multicenter, international observational retrospective study. Patients admitted in the ICU between March 1th and april 26th for a pneumonia related to SARS COV 2 and who had at least one echocardiogra...
Eligibility Criteria
Inclusion
- patients admitted in the ICU for pneumonia related to SARS COV2 and who had at least 1 critical care echocardiography during the first 28 days.
- \-
Exclusion
- Patients who did not have any critical care echocardiography during the first 28 days of the ICU stay.
Key Trial Info
Start Date :
May 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2021
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04414410
Start Date
May 12 2020
End Date
September 30 2021
Last Update
April 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ambroise Pare
Boulogne-Billancourt, Hauts De Seine, France, 92100